日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment

KRASG12R突变型胰腺癌具有ERK/MAPK转录活性受限和独特的肿瘤微环境。

Burge, Rachel A; Le Roux, Ozgun; Popow, Olesja; Spadafora, Victoria K; Rajesh, Christabelle; Adair, Sara J; Bialousow, Lucas; Murphy, Cailey; Saberi, Samaneh; Vaena, Silvia G; Taquey, Margaret C; Allen, Sarah; Han, Lu; Helke, Kristi L; Sharma, Sudarshana; Ostrowski, Michael C; Guttridge, Denis C; Dincman, Toros A; Bauer, Todd W; Kashatus, David F; McFall, Thomas; Haigis, Kevin M; Hollingsworth, Michael A; Counter, Christopher M; Der, Channing J; Hobbs, G Aaron

Loss of inducible nitric oxide synthase promotes Kras/Pten-driven lung tumorigenesis.

诱导型一氧化氮合酶的缺失促进 Kras/Pten 驱动的肺肿瘤发生。

Kabiri Zahra, Zaribafzadeh Hamed, Raji Sara, Carney John M, Counter Christopher M

The essential clathrin adapter protein complex-2 is tumor suppressive specifically in vivo.

必需的网格蛋白衔接蛋白复合物-2在体内具有肿瘤抑制作用

Zimmerman Seth P, DeGraw Lili B, Counter Christopher M

CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

CDK8 抑制剂可解除融合驱动型肺泡横纹肌肉瘤中的肌肉分化阻滞

Zhang Susu, Engel Kathleen, Fahs Assil, Malone Clare F, Ross Kenneth, Just Marissa, Guedes Brian, Granum Diyana, Oristian Kristianne M, Kovach Alexander, Alexe Gabriela, Digiovanni Giulia, Barbar Leen, Bentley Rex, Cerda-Smith Christian, Le Roux Ozgun, Mendes Elizabeth, Zimmerman Seth P, Rees Matthew, Roth Jennifer, Shern Jack F, Wood Kris C, Counter Christopher M, Linardic Corinne M, Stegmaier Kimberly

p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis

p53剂量可以抑制KrasG12D和KrasQ61R介导的肿瘤发生

Le Roux, Özgün; Everitt, Jeffery I; Counter, Christopher M

Distinct responses to rare codons in select Drosophila tissues.

果蝇特定组织对稀有密码子表现出不同的反应

Allen Scott R, Stewart Rebeccah K, Rogers Michael, Ruiz Ivan Jimenez, Cohen Erez, Laederach Alain, Counter Christopher M, Sawyer Jessica K, Fox Donald T

Non-canonical genomic driver mutations of urethane carcinogenesis.

非典型基因组驱动突变导致氨基甲酸乙酯致癌

Li Siqi, Counter Christopher M

Capturing the primordial Kras mutation initiating urethane carcinogenesis.

捕获引发氨基甲酸乙酯致癌作用的原始 Kras 突变

Li Siqi, MacAlpine David M, Counter Christopher M

Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of Kras mutation-positive, non-small cell lung cancer

在Kras突变阳性的非小细胞肺癌小鼠模型中,使用一氧化氮合酶抑制剂L-NAME进行治疗可延长小鼠的生存期。

Pershing, Nicole L K; Yang, Chi-Fu Jeffrey; Xu, MengMeng; Counter, Christopher M

A Genetic Porcine Model of Cancer

癌症的遗传猪模型

Schook, Lawrence B; Collares, Tiago V; Hu, Wenping; Liang, Ying; Rodrigues, Fernanda M; Rund, Laurie A; Schachtschneider, Kyle M; Seixas, Fabiana K; Singh, Kuldeep; Wells, Kevin D; Walters, Eric M; Prather, Randall S; Counter, Christopher M